The WHO against influenza strategy focuses on research and programs for vulnerable numbers


The World Health Organization (WHO) 2019-2030 (WHO) Anti-flu Strategy aims to explore research, innovation and surveillance and the expansion of prevention programs to protect the most vulnerable populations.

The WHO document focuses on encouraging research and innovation to address unprecedented public health needs and building into research to develop new diagnostic devices, vaccines and treatments for flu.

It also provides for research to encourage a better understanding of the characteristics of viruses and things related to guests who affect the impact of flu, and to strengthen surveillance, monitoring and surveillance. using data from all over the world to create a strong database and; develop effective communication strategies.

"Despite the progress made, there are still many challenges and gaps," the WHO notes in the document, the boundary marking and control cap (virus) limit, the annual requirement for seasonal vaccination and the restriction of treatment options.

For WHO, "urgent need to improve mechanisms for preventing, detecting, controlling and treating flu, including more effective vaccines and antiviral drugs that can inspire and influence the public. T to increase. "

"Many countries have invested in public health systems to identify, respond and dispose of gases that can affect their land and are not ready for breaking up. on a medium or poor scale pandemic scale. "

The strategy focuses on two key aspects: the development of better global instruments – such as vaccines, antibiotics and treatments – which benefit all countries and build confidence in the population, as well as on national health security planning and efforts to achieve universal health care.

"The risk from pandemic is always present," said WHO Tedros Adhanom Ghebreyesus, adding, "There is a real risk that an influenza virus will be transmitted from animals to people and that people may have a new t There is no question about whether our other pandemic is due, but when will that be.

"The cost of flu is much higher than the cost of a ban," he said.

According to WHO data, every year there are 1 billion cases in the world, and between three and five million of them are bad and between 290,000 and 650,000 people die from flu-related respiratory illness.

The organization recommends annual vaccination as the most effective way to prevent flu, particularly with people at high risk of serious problems and in health professionals.

In the strategy presented today, WHO wishes to see science-based immunization policies and programs developed and implemented to reduce uncertainty and death, as well as dissemination and deprivation. disease.

It stresses the importance of each country having its own program that contributes to national and global planning and health security.

The WHO also emphasizes the need to develop better mechanisms for preventing, detecting, managing and treating flu, such as vaccines, antivirals and more efficient treatment, with the aim of getting more t These are available to all countries.

“With the partnerships and work we have ever done over the years, the world is better than ever before for the next stage, but we're still not ready enough,” t said Tedros.

To successfully implement this strategy, WHO believes it is essential to broaden partnerships to increase research, innovation and access to new and more effective tools for each nation.

"At the same time, the WHO will work closely with countries to improve their ability to flu and control capacity," the report said.

The strategy highlights the importance of the continued success of the Pandemic Ear Preparation Framework, a dedicated access system and sharing of benefits that supports the sharing of information on viruses that provide exposure to vaccines, giving access to vaccines. and medicines which will save from a pandemic, and support the preparation of a pandemic disease through partnerships with industry.

WHO also believes that supportive countries will have benefits to help them strengthen their ability to combat the virus, by detecting general diseases because countries can identify other infectious diseases, such as coronavirus. T , associated with respiratory syndrome. Ebola or the Middle East (MERS-CoV).

"Influenza is also a threat to other health risks around the world, including non-controversial diseases (NCDs), poor physical disease and anti-detection (ADR) disorder," said the paper beforehand. T , designed by WHO as a "global call" for all nations to prioritize flower programs as investment strengthens the health system and prepares it for pandemics.

Source link